Department of Nutrition and Health Sciences, University of Nebraska, Lincoln, NE 68583, USA.
Nutr Res. 2009 Dec;29(12):859-66. doi: 10.1016/j.nutres.2009.10.016.
Intake of plant sterols has long been shown to reduce cholesterol absorption and subsequently plasma cholesterol concentrations. Despite competition between plant sterols and cholesterol for incorporation into mixed micelles as a suggested major mechanism for the inhibition of cholesterol absorption by plant sterols, studies exist to support an alternative mechanism. For example, another mechanism may be the action of plant sterols to reduce cholesterol absorption at the cellular level. This study was undertaken to test the hypothesis that plant sterols can modulate the expression of transporters such as Niemann-Pick C1-like 1 (NPC1L1) and scavenger receptor class B, type I (SR-BI) to lower intestinal cholesterol absorption. FHs 74 Int cells, a human small intestine epithelial cell line, were used as a model of enterocytes. The cells were treated with 25alpha-hydroxycholesterol (25 micromol/L) or 250 micromol/L of sitosterol, stigmasterol, and cholesterol for 24 hours to measure genes involved in cholesterol absorption and metabolism by quantitative real-time polymerase chain reaction. 25Alpha-hydroxycholesterol, cholesterol, and sitosterol significantly reduced the messenger RNA (mRNA) expression of NPC1L1 and hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, whereas SR-BI mRNA was not altered by the sterols. Western blot analysis confirmed the reduction in NPC1L1 by sterols. Depletion of cellular cholesterol by mevinolin, a cholesterol synthesis inhibitor, increased NPC1L1 and HMG-CoA reductase mRNA; and repletion of cholesterol abolished the increase. Sitosterol, but not stigmasterol, reduced the mRNA levels of NPC1L1 and HMG-CoA reductase to a similar extent of cholesterol. In conclusion, sitosterol can inhibit the expression of NPC1L1 in the enterocytes, which could be an alternate mechanism for plant sterols to reduce intestinal cholesterol uptake.
植物固醇的摄入早已被证明可以降低胆固醇的吸收,从而降低血浆胆固醇浓度。尽管植物固醇与胆固醇竞争掺入混合胶束作为植物固醇抑制胆固醇吸收的主要机制之一,但也有研究支持替代机制。例如,另一种机制可能是植物固醇在细胞水平上降低胆固醇的吸收。本研究旨在检验植物固醇是否可以调节 NPC1L1 等转运蛋白的表达,从而降低肠道胆固醇吸收的假设。FHs 74 Int 细胞是一种人小肠上皮细胞系,被用作肠细胞模型。用 25α-羟基胆固醇(25μmol/L)或 250μmol/L 的豆固醇、β-谷固醇和胆固醇处理细胞 24 小时,通过实时定量聚合酶链反应测量参与胆固醇吸收和代谢的基因。25α-羟基胆固醇、胆固醇和豆固醇显著降低了 NPC1L1 和羟甲基戊二酰辅酶 A(HMG-CoA)还原酶的信使 RNA(mRNA)表达,而固醇对 SR-BI mRNA 没有影响。Western blot 分析证实了固醇对 NPC1L1 的减少。胆固醇合成抑制剂 mevinolin 耗尽细胞胆固醇会增加 NPC1L1 和 HMG-CoA 还原酶 mRNA;胆固醇补充则会消除这种增加。豆固醇而不是β-谷固醇,将 NPC1L1 和 HMG-CoA 还原酶的 mRNA 水平降低到与胆固醇相似的程度。总之,植物固醇可以抑制肠细胞中 NPC1L1 的表达,这可能是植物固醇降低肠道胆固醇摄取的另一种机制。